Cancer as Coherence Collapse: A Multilevel Recursive Coherence Perspective on Malignant Transformation

Cancer remains paradoxical: cells that are genetically ``self'' become existential threats. Conventional models focus on accumulated mutations and oncogene/tumor-suppressor imbalances. Yet they struggle to explain why identical mutations produce different outcomes, why some tumors remain dormant for decades, why the tumor microenvironment often matters more than the tumor itself, and why some patients experience spontaneous remission while others with smaller tumors deteriorate rapidly. This article applies the Multilevel Recursive Coherence (MRC) framework to malignant transformation. We propose that cancer represents not genetic error but coherence collapse}---a breakdown in the oscillatory synchronization that normally maintains tissue identity and coordinates cellular behavior with organismal needs. The malignant cell is a ``double agent'': it retains surface credentials of tissue membership while pursuing an autonomous agenda decoupled from systemic coherence. Advanced cancer kills not primarily through mechanical obstruction or resource competition, but through progressive degradation of the organism's electromagnetic coordination capacity. Four convergent lines of evidence support this framework: (1) circadian clock genes are systematically disrupted in tumors, with loss of BMAL1 rhythmicity precedingand facilitating transformation; (2) tumors exhibit altered electrical impedance detectable before morphological changes; (3) chronotherapy demonstrates that treatment timing affects both efficacy and toxicity; (4) tumor-treating fields (TTFields) show that electromagnetic perturbation can selectively target malignant cells. The framework generates falsifiable predictions regarding early detection via electromagnetic profiling and therapeutic approaches focused on coherence maintenance as adjuvant to existing treatments. While this paper was in preparation, we discover that two independent research groups published experimental findings that converge with the theoretical framework resented here. Skrupskelyte, Alcolea et al. demonstrated that early tumors actively remodel their microenvironment to create a protective precancerous niche, and that a sufficiently degraded microenvironment can confer tumorigenic properties even to unmutated cells. Thiel et al. showed that pancreatic cancer reprograms neurons for its own benefit, and that blocking this neural connection inhibits tumor growth and restores sensitivity to chemotherapy and immunotherapy. Both findings emerge as predicted consequences of the MRC framework: the tumor does not merely occupy a pathological attractor---it actively corrupts the coherence infrastructure of the organism. The MRC framework provides the biophysical substrate from which these experimental observations arise. The biophysical formalization of these mechanisms is developed in a companion paper to be published soon.